Olympios Papadimitriou holds the position of General Manager at Novo Nordisk Hellas. He started his career in the pharmaceutical sector in 1990, working as a sales representative at Wyeth (later absorbed by Pfizer), based in Thessaloniki. In less than a year, he joined Schering AG Berlin (later absorbed by Bayer). After completing a three-year term at Schering AG, he joined Novo Nordisk Hellas as a medical representative in 1994. He served for 6 years in the field of medical sales, and then for 5 years in the marketing department of diabetes. He took over the general management of Novo Nordisk Hellas in December 2005
He has been a member of the Board of Directors of SFEE since 2013, and as of March 2018 he holds the president’s position at SFEE.
Olympios Papadimitriou is a graduate of the German School of Thessaloniki and he also holds a Diploma in Chemistry from Aristotelion University of Thessaloniki. He has attended Young Manager’s Program at INSEAD and he speaks fluently English and German.